Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of Colorado, a Body Corporate”
252 pharma patents match "The Regents of the University of Colorado, a Body Corporate" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 252 pharmaceutical patents matching "The Regents of the University of Colorado, a Body Corporate" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8163509
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
granted -
US 8138312
Compositions for regulation of tumor necrosis factor-alpha
granted -
US 8093286
Methods for treatment with bucindolol based on genetic targeting
granted -
US 8080578
Methods for treatment with bucindolol based on genetic targeting
granted -
US 8057807
Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction
granted -
US 8039001
Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
granted -
US 8017321
Gefitinib sensitivity-related gene expression and products and methods related thereto
granted -
US 7976851
Non-toxic biofilm inhibitor
granted -
US 7678824
Methods for treatment with bucindolol based on genetic targeting
granted -
US 7560265
Compositions for regulation of tumor necrosis factor-alpha
granted -
US 7361355
Mutant forms of cholera holotoxin as an adjuvant
granted -
US 7285281
Mutant forms of cholera holotoxin as an adjuvant
granted